M. W. Peck, T. J. Smith, F. Anniballi, J. W. Austin, L. Bano et al., Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature, Toxins, vol.9, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01821691

J. Sobel and . Botulism, Clin. Infect. Dis, vol.41, pp.1167-1173, 2005.

I. Brook, Botulism symptoms, incubation period and complications, diagnosis and management. In Clostridium Botulinum: A Spore Forming Organism and a Challenge to Food Safety; Advances in Food Safety and Food Microbiology, 2012.

D. M. Gill, Bacterial toxins: A table of lethal amounts, Microbiol. Rev, vol.46, pp.86-94, 1982.

S. S. Arnon, R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett et al., Botulinum toxin as a biological weapon: Medical and public health management, JAMA, vol.285, pp.1059-1070, 2001.

G. Bozheyeva, Y. Kunakbayev, and D. Yeleukenov, Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future, Monterey Institute of International Studies, issue.1, 1999.

L. M. Wein and Y. Liu, Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk, Proc. Natl. Acad. Sci, vol.102, pp.9984-9989, 2005.

K. Jalava, K. Selby, A. Pihlajasaari, E. Kolho, E. Dahlsten et al., Two cases of food-borne botulism in Finland caused by conserved olives, Euro Surveill, vol.16, 2011.

J. M. Pingeon, C. Vanbockstael, M. R. Popoff, L. A. King, B. Deschamps et al., Two outbreaks of botulism associated with consumption of green olive paste, Euro Surveill, vol.16, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01763106

J. A. Coffield, N. Bakry, J. Carlson, L. G. Gomella, and L. L. Simpson, In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches, J. Pharmacol. Exp. Ther, vol.280, pp.1489-1498, 1997.

J. R. Barash and S. S. Arnon, A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins, J. Infect. Dis, vol.209, pp.183-191, 2014.

N. Dover, J. R. Barash, K. K. Hill, G. Xie, and S. S. Arnon, Molecular characterization of a novel botulinum neurotoxin type H gene, J. Infect. Dis, vol.209, pp.192-202, 2014.

S. E. Maslanka, C. Lúquez, J. K. Dykes, W. H. Tepp, C. L. Pier et al., A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, has a Hybrid-Like Structure with Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin, J. Infect. Dis, vol.213, pp.379-385, 2016.

M. J. Mansfield, T. G. Wentz, S. Zhang, E. J. Lee, M. Dong et al., Newly identified relatives of botulinum neurotoxins shed light on their molecular evolution, 2017.

M. J. Mansfield, J. B. Adams, and A. C. Doxey, Botulinum neurotoxin homologs in non-Clostridium species, FEBS Lett, vol.589, pp.342-348, 2015.

S. Zhang, G. Masuyer, J. Zhang, Y. Shen, D. Lundin et al., Identification and characterization of a novel botulinum neurotoxin, Nat. Commun, vol.8, 2017.

D. B. Lacy, W. Tepp, A. C. Cohen, B. R. Dasgupta, and R. C. Stevens, Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nat. Struct. Biol, vol.5, pp.898-902, 1998.

D. Kumaran, S. Eswaramoorthy, W. Furey, J. Navaza, M. Sax et al., Domain organization in Clostridium botulinum neurotoxin type E is unique: Its implication in faster translocation, J. Mol. Biol, vol.386, pp.233-245, 2009.

G. Schiavo, M. Matteoli, and C. Montecucco, Neurotoxins affecting neuroexocytosis, Physiol. Rev, vol.80, pp.717-766, 2000.

M. Montal, Botulinum neurotoxin: A marvel of protein design, Annu. Rev. Biochem, vol.79, pp.591-617, 2010.

A. V. Benedetto, The cosmetic uses of botulinum toxin type A, Int. J. Dermatol, vol.38, pp.641-655, 1999.

K. Turton, J. A. Chaddock, and K. R. Acharya, Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility, Trends Biochem. Sci, vol.27, pp.552-558, 2002.

Y. Fujinaga, Y. Sugawara, and T. Matsumura, Uptake of botulinum neurotoxin in the intestine, Curr. Top. Microbiol. Immunol, vol.364, pp.45-59, 2013.

C. Connan and M. R. Popoff, Two-component systems and toxinogenesis regulation in Clostridium botulinum, Res. Microbiol, vol.166, pp.332-343, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01115185

L. L. Simpson, Identification of the major steps in botulinum toxin action, Annu. Rev. Pharmacol. Toxicol, vol.44, pp.167-193, 2004.

B. C. Yowler, R. D. Kensinger, and C. Schengrund, Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I, J. Biol. Chem, vol.277, pp.32815-32819, 2002.

A. Rummel, T. Eichner, T. Weil, T. Karnath, A. Gutcaits et al., Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept, Proc. Natl. Acad. Sci, vol.104, pp.359-364, 2007.

P. Stenmark, J. Dupuy, A. Imamura, M. Kiso, and R. C. Stevens, Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction, PLoS Pathog, 2008.

R. P. Berntsson, L. Penh, M. Dong, and P. Stenmark, Structure of dual receptor binding to botulinum neurotoxin B, Nat. Commun, 2013.

M. A. Benson, Z. Fu, J. J. Kim, and M. R. Baldwin, Unique ganglioside recognition strategies for clostridial neurotoxins, J. Biol. Chem, vol.286, pp.34015-34022, 2011.

Z. Fu, C. Chen, J. T. Barbieri, J. J. Kim, and M. R. Baldwin, Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F, Biochemistry, vol.48, pp.5631-5641, 2009.

A. Rummel, S. Mahrold, H. Bigalke, and T. Binz, The HcC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction, Mol. Microbiol, vol.51, pp.631-643, 2004.

A. Rummel, T. Karnath, T. Henke, H. Bigalke, and T. Binz, Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G, J. Biol. Chem, vol.279, pp.30865-30870, 2004.

A. Rummel, K. Hafner, S. Mahrold, N. Darashchonak, M. Holt et al., Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor, J. Neurochem, vol.110, pp.1942-1954, 2009.

J. Schmidt, A. Karalewitz, D. A. Benefield, D. J. Mushrush, R. N. Pruitt et al., Structural analysis of botulinum neurotoxin type G receptor binding, Biochemistry, vol.49, pp.5200-5205, 2010.

T. Nishiki, Y. Kamata, Y. Nemoto, A. Omori, T. Ito et al., Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes, J. Biol. Chem, vol.269, pp.10498-10503, 1994.

M. Dong, F. Yeh, W. H. Tepp, C. Dean, E. A. Johnson et al., SV2 is the protein receptor for botulinum neurotoxin A. Science, vol.312, pp.592-596, 2006.

S. Mahrhold, A. Rummel, H. Bigalke, B. Davletov, and T. Binz, The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves, FEBS Lett, vol.580, 2006.

A. Rummel, Two Feet on the Membrane: Uptake of Clostridial Neurotoxins, Curr. Top. Microbiol. Immunol, vol.406, pp.1-37, 2017.

S. Sun, H. Suresh, H. Liu, W. H. Tepp, E. A. Johnson et al., Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly, Cell Host Microbe, vol.10, pp.237-247, 2011.

J. Strohmeier, K. Lee, A. K. Volker, S. Mahrold, Y. Zong et al., Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner, Biochem. J, vol.431, pp.207-216, 2010.

S. Zhang, R. P. Berntsson, W. H. Tepp, L. Tao, E. A. Johnson et al., Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC, Nat. Commun, 1637.

D. Stern, J. Weisemann, A. Le-blanc, L. Berg, S. Mahrhold et al., A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency, PLoS Pathog, vol.14, 2018.

M. R. Baldwin, J. P. Kim, and J. T. Barbieri, Botulinum neurotoxin B-host receptor recognition: It takes two receptors to tango, Nat. Struct. Mol. Biol, vol.14, pp.9-10, 2007.

S. Gu, S. Rumpel, J. Zhou, J. Strotmeier, H. Bigalke et al., Botulinum neurotoxin is shielded by NTNHA in an interlocked complex, Science, vol.335, pp.977-981, 2012.

L. Muraro, S. Yosatto, L. Motterlini, O. Rossetto, and C. Montecucco, The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane, Biochem. Biophys. Res. Commun, vol.380, pp.76-80, 2009.

Q. Chai, J. W. Arndt, M. Dong, W. H. Tepp, E. A. Johnson et al., Structural basis of cell surface receptor recognition by botulinum neurotoxin B, Nature, vol.444, pp.1096-1100, 2006.

J. Meng, J. Wang, G. W. Lawrence, and J. O. Dolly, Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons, FASEB J, vol.27, pp.3167-3180, 2013.

A. Couesnon, Y. Pereira, and M. R. Popoff, Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers, Cell. Microbiol, vol.10, pp.375-387, 2008.

A. Couesnon, T. Shimizu, and M. R. Popoff, Differential entry of botulinum neurotoxin A into neuronal and intestinal cells, Cell. Microbiol, vol.11, pp.289-308, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-01758348

C. Connan and M. R. Popoff, Uptake of Clostridial Neurotoxins into Cells and Dissemination, Curr. Top. Microbiol. Immunol, vol.406, pp.39-78, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01826649

T. Matsumura, Y. Sugawara, M. Yutani, S. Amatsu, H. Yagita et al., Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity, Nat. Commun, vol.6, 2015.

D. Kim, S. K. Lee, and J. Ahnn, Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception, Toxins, vol.7, pp.2435-2453, 2015.

S. A. Grando and C. B. Zachary, The Non-Neuronal and Non-Muscular Effects of Botulinum Toxin: A Graceful Opportunity for a Deadly Molecule to Treat a Human Disease in the Skin and Beyond, Br. J. Dermatol, vol.178, pp.1011-1019, 2018.

I. Anza, H. Skarin, D. Vidal, A. Lindberg, V. Baverud et al., The same clade of Clostridium botulinum strains is causing avian botulism in southern and northern Europe, Anaerobe, vol.26, pp.20-23, 2014.

C. Woudstra, H. Skarin, F. Anniballi, L. Fenicia, L. Bano et al., Neurotoxin gene profiling of Clostridium botulinum types C and D native to different countries within, Europe. Appl. Environ. Microbiol, vol.78, pp.3120-3127, 2012.

M. R. Popoff, Ecology of neurotoxigenic strains of clostridia, Curr. Top. Microbiol. Immunol, vol.195, pp.1-29, 1995.

B. Davletov, M. Bajohrs, T. Binz, . Beyond, and . Botox, Advantages and limitations of individual botulinum neurotoxins, Trends Neurosci, vol.8, pp.446-452, 2005.

J. E. Keller, Recovery from botulinum neurotoxin poisonning in vivo, Neuroscience, vol.139, pp.629-637, 2006.

J. Wang, J. Meng, G. W. Lawrence, T. H. Zurawski, A. Sasse et al., Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics, J. Biol. Chem, vol.283, pp.16993-17002, 2008.

A. Megighian, M. Zordan, S. Pantano, M. Scorzeto, M. Rigoni et al., Evidence for a radial SNARE super-complex mediating neurotransmitter release at the Drosophila neuromuscular junction, J. Cell Sci, vol.126, pp.3134-3140, 2013.

S. Pantano and C. Montecucco, The blockade of the neurotransmitter release apparatus by botulinum neurotoxins, Cell. Mol. Life Sci, vol.71, pp.793-811, 2014.

R. L. Whittaker, R. B. Gilbertson, A. S. Garrett, . Jr, and . Botulism, Report of eight simultaneous cases, Ann. Intern. Med, vol.61, pp.448-454, 1964.

R. C. Whitemarsh, W. H. Tepp, M. Bradshaw, G. Lin, C. L. Pier et al., Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro, Infect. Immun, vol.81, pp.3894-3902, 2013.

W. H. Tepp, G. Lin, and E. A. Johnson, Purification and characterization of a novel subtype A3 botulinum neurotoxin, Appl. Environ. Microbiol, vol.78, pp.3108-3113, 2012.

R. C. Whitemarsh, W. H. Tepp, E. A. Johnson, and S. Pellett, Persistence of botulinum neurotoxin A subtypes 1-5 in primary rat spinal cord cells, PLoS ONE, vol.9, 2014.

J. S. Henkel, M. Jacobson, W. Tepp, C. Pier, E. A. Johnson et al., Catalytic properties of botulinum neurotoxin subtypes A3 and A4, Biochemistry, vol.48, pp.2522-2528, 2009.

A. R. Kroken, F. C. Blum, M. Zuverink, and J. T. Barbieri, Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons, Infect. Immun, vol.85, 2016.

J. R. Davies, J. Rees, S. M. Liu, and K. R. Acharya, High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains, J. Struct. Biol, vol.202, pp.113-117, 2018.

R. J. Erbguth and M. Naumann, Historical Aspects of Botulinum Toxin: Justinus Kerner (1786-1862) and the "Sausage Poison, Neurology, vol.53, pp.1850-1853, 1999.

M. F. Brin, Development of future indications for BOTOX, vol.54, pp.668-674, 2009.

K. R. Aoki and J. Francis, Updates on the antinociceptive mechanism hypothesis of botulinum toxin A, Parkinsonism Relat. Disord, vol.17, pp.28-33, 2011.

V. S. Hanchanale, A. R. Rao, F. L. Martin, and S. S. Matanhelia, The unusual history and the urological applications of botulinum neurotoxin, Urol. Int, vol.85, pp.125-130, 2010.

D. M. Simpson, M. Hallett, E. J. Ashman, C. L. Comella, M. W. Green et al., Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Neurology, vol.86, pp.1818-1826, 2016.

R. M. Benoit, D. Frey, M. Hilbert, J. T. Kevenaar, M. M. Wieser et al., Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A, Nature, vol.505, pp.108-111, 2014.

S. Pellett, M. Bradshaw, W. H. Tepp, C. L. Pier, R. C. Whitemarsh et al., The Light Chain Defines the Duration of Action of, Botulinum Toxin Serotype A Subtypes. MBio, vol.9, 2018.

M. Caleo, F. Antonucci, L. Restani, and R. Mazzocchio, A reappraisal of the central effects of botulinum neurotoxin type A: By what mechanism?, J. Neurochem, vol.109, pp.15-24, 2009.

M. Caleo and G. Schiavo, Central effects of tetanus and botulinum neurotoxins, Toxicon, vol.54, pp.593-599, 2009.

L. Restani, F. Giribaldi, M. Manich, K. Bercsenyi, G. Menendez et al., Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons, PLoS Pathog, vol.8, 2012.

S. O. Ali, M. Thomassen, G. M. Schulz, L. A. Hosey, M. Varga et al., Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: An H2O15 PET study, J. Speech Lang Hear. Res, vol.49, pp.1127-1146, 2006.

K. Kato, T. Kohda, and S. Kozaki, Application of botulinum neurotoxin in the treatment of epilepsy, Brain Nerve, vol.61, pp.939-948, 2009.

G. Abbruzzese and A. Berardelli, Sensorimotor Integration in Movement Disorders, Mov. Disord, vol.18, pp.231-240, 2003.

A. O. Ceballos-baumann, G. Sheean, R. E. Passingham, C. D. Marsden, and D. J. Brooks, Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp: A PET study, Brain, vol.120, pp.571-582, 1997.

F. J. Palomar and P. Mir, Neurophysiological changes after intramuscular injection of botulinum toxin, Clin. Neurophysiol, vol.123, pp.54-60, 2012.

C. P. Das, D. Dressler, and M. Hallett, Botulinum toxin therapy of writer's cramp, Eur. J. Neurol, vol.13, pp.55-59, 2006.

M. Hallett, Mechanism of action of botulinum neurotoxin: Unexpected consequences, Toxicon, vol.147, pp.73-76, 2018.

C. Dresel, B. Haslinger, F. Castrop, A. M. Wohlschlaeger, and A. O. Ceballos-baumann, Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia, Brain, vol.129, pp.36-46, 2006.

R. M. Kostrzewa, R. A. Kostrzewa, and J. P. Kostrzewa, Botulinum neurotoxin: Progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering. MiniReview. Peptides, vol.72, pp.80-87, 2015.

S. Sikorra, C. Litschko, C. Müller, N. Thiel, T. Galli et al., Identification and Characterization of Botulinum Neurotoxin A Substrate Binding Pockets and Their Re-Engineering for Human SNAP-23
URL : https://hal.archives-ouvertes.fr/hal-01269586

, J. Mol. Biol, vol.428, pp.372-384, 2016.

C. Rasetti-escargueil, A. Avril, S. Miethe, C. Mazuet, Y. Derman et al., The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies, Toxins, vol.9, 2017.